浙江恒康药业股份有限公司

Zhejiang Hengkang Pharmaceutical Co. Ltd.

Country: CN CDE+DMF+CEP VERY_HIGH

🇨🇳 CDE

11

11 products shown

🇺🇸 DMF

6

6 products shown

🇪🇺 CEP

12

12 products shown

Total

29

registrations

🇨🇳 CDE 注册 (11)

Product CAS Status Reg Number
Amiodarone Hydrochloride

盐酸胺碘酮

19774-82-4 Class A Y20190007055
Benserazide

盐酸苄丝肼

- Class A Y20170000662
Eltrombopag Olamine

艾曲泊帕乙醇胺

496775-61-2 Class A Y20220000112
Esmolol

盐酸艾司洛尔

81147-92-4 Class A Y20240000075
Fenofibrate

NH600001

49562-28-9 Class I Y20250001479
Iguratimod

艾拉莫德

123663-49-0 Class A Y20240000734
Ilaprazole

艾普拉唑

172152-36-2 Class A Y20230001213
Ilaprazole Sodium

艾普拉唑钠

172152-50-0 Class A Y20230001212
Mesalazine

美沙拉嗪

89-57-6 Class A Y20190000586
Upadacitinib

乌帕替尼

1310726-60-3 Class I Y20250000984
Vonoprazan

富马酸伏诺拉生

881681-00-1 Class A Y20230000304

🇺🇸 DMF 注册 (6)

Product CAS DMF Number Date
Amiodarone Hydrochloride

盐酸胺碘酮

19774-82-4 24518 2010-12-29
Deferasirox

地拉罗司

201530-41-8 41051 2024-12-31
Dmt-2'-o-me-g(ibu)-ce Phosphoramidite 150780-67-9 40638 2024-12-27
Eltrombopag Olamine

艾曲泊帕乙醇胺

496775-61-2 40357 2024-11-25
Mesalamine USP

美沙拉秦(SH级)

89-57-6 37319 2022-08-17
Vonoprazon Fumarate 881681-01-2 40356 2024-12-29

🇪🇺 CEP 注册 (12)

Product CAS CEP Number Date
Acemetacin

阿西美辛

53164-05-9 R0-CEP 2017-300 - Rev 01 2019-11-27
Acemetacin, Pubagang Site

阿西美辛

53164-05-9 R0-CEP 2022-226 - Rev 00 2022-11-10
Amiodarone Hydrochloride

盐酸胺碘酮

19774-82-4 R1-CEP 2007-187 - Rev 04 2019-12-12
Amiodarone Hydrochloride, Pubagang Site 19774-82-4 CEP 2021-349 - Rev 01 2025-09-05
Benserazide Hydrochloride

盐酸苄丝肼

14919-77-8 R0-CEP 2018-183 - Rev 00 2021-09-27
Benserazide Hydrochloride, Pubagang Site 14919-77-8 CEP 2022-310 - Rev 01 2023-12-11
Deferasirox

地拉罗司

201530-41-8 CEP 2024-292 - Rev 00 2024-12-18
Mesalazine, Hp

美沙拉秦(SH级)

89-57-6 R1-CEP 2015-209 - Rev 00 2021-05-06
Mesalazine, Pubagang Site

美沙拉秦(SH级)

89-57-6 CEP 2021-400 - Rev 01 2025-12-10
Riociguat

利奥西呱

625115-55-1 CEP 2025-649 - Rev 00 2026-06-24
Tenoxicam 59804-37-4 R1-CEP 2011-331 - Rev 02 2019-11-18
Tenoxicam, Pubagang Site

替诺昔康

59804-37-4 CEP 2025-530 - Rev 00 2026-03-09

Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-11 06:00:12